Bailey Pemberton
4 min read
STAAR Surgical has seen its share price move around over the years, which puts a spotlight on a simple question for investors who care about fundamentals. Is the current US$24.56 price properly anchored to the cash flows the business can realistically generate?
-
The stock has fallen 78.8% over 5 years, which raises the question of whether today’s valuation still lines up with the underlying cash flow profile or reflects a very different set of expectations.
-
An ongoing investigation into potential fiduciary breaches by certain STAAR Surgical officers and directors can influence how investors think about governance quality, which in turn may affect the confidence they place in future cash flow delivery and capital allocation.
-
What if you looked at STAAR Surgical through its sales instead? See why STAAR Surgical’s 3.6x P/S tells a different valuation story.
The issue now is whether STAAR Surgical’s current share price can be explained by what its cash flows suggest the business is worth.
If you want a comparison point for STAAR Surgical’s cash flow story and recent share price decline, it can help to line it up next to 29 high quality undervalued stocks.
Is STAAR Surgical a Bargain on Cash Flow?
The Discounted Cash Flow (DCF) model here focuses on what STAAR Surgical can generate for shareholders over time rather than where earnings sit today. Latest twelve month free cash flow shows a loss of about $19.1 million, yet the projections assume that cash generation recovers and grows into positive territory over the next decade. On that basis, the model points to an estimated intrinsic value that sits modestly above the current US$24.56 share price.
The gap partly reflects trust issues. The ongoing investigation into possible fiduciary breaches by certain STAAR Surgical officers and directors gives investors a concrete governance risk to weigh against those improving cash flow assumptions. For anyone comparing the legal overhang with the cash flow outlook, the DCF suggests the market is pricing in a fair amount of caution at today’s level. Find out what STAAR Surgical could be worth using our Discounted Cash Flow (DCF) estimate.
The STAAR Surgical Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives pick up where that valuation puzzle for STAAR Surgical leaves off by explaining which growth, margin and earnings paths would need to occur for the share price to look meaningfully higher or lower than today. Each narrative links its figures to a clear view on how STAAR Surgical’s growth, profitability profile and key risks might evolve, giving you something concrete to revisit as new information appears on the Community page.
